REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Research and development, 2025
- $5.9B
- YoY, 2025
- +14.0%
- 5-year CAGR
- +17.2%
- 10-year CAGR
- +13.7%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $5.9B | +14.0% |
| 2024 | $5.1B | +15.6% |
| 2023 | $4.4B | +23.6% |
| 2022 | $3.6B | +25.6% |
| 2021 | $2.9B | +8.1% |
| 2020 | $2.6B | +8.0% |
| 2019 | $2.5B | +66.8% |
| 2018 | $1.5B | −29.2% |
| 2017 | $2.1B | +1.1% |
| 2016 | $2.1B | +26.6% |
| 2015 | $1.6B | +27.5% |
| 2014 | $1.3B | +47.8% |
| 2013 | $860M | +37.5% |
| 2012 | $626M | +18.1% |
| 2011 | $530M | +8.2% |
| 2010 | $489M | +22.7% |
| 2009 | $399M | +45.1% |
| 2008 | $275M | — |